Is Viatris Stock Good for Dividend Income?
Viatris (NASDAQ: VTRS) is a stock of immense interest among the dividend investing community, and it's no surprise why. Generic drugmakers, when operating smoothly, can be veritable cash machines for years on end.
But as all investors should know, companies don't always live up to the promise of their archetype. So let's take a closer look at Viatris and judge its suitability for dividend income to see if you might want to add it to your portfolio.
Right off the bat, investors should notice that Viatris has all the makings of an ideal dividend stock. Its line of business, manufacturing branded and complex generic medications that have large and established markets, is one that is inherently stable. With all else being equal, people tend to prefer buying cheaper medicines when they're able to, and once they're taking a drug to manage a chronic condition, they're reliable contributors to demand for years.
Source Fool.com
